-
Jill Malandrino Details What To Know Ahead Of FedEx Earnings
Tuesday, June 16, 2015 - 3:31pm | 417Read More...Jill Malandrino was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. TheStreet's Options Profits Product Development Manager Jill Malandrino argued that FedEx Corporation (NYSE: FDX) was a "bellwether benchmark" that...
-
Why Avalanche Biotechnologies Is Coming Off A Big Day
Thursday, June 11, 2015 - 9:10am | 340Read More...Shares of Avalanche Biotechnologies Inc (NASDAQ: AAVL) closed up more than 7 percent on Wednesday following positive commentary by TheStreet.com. According to author Alfredo Fontanini, the company is approaching an important clinical trial catalyst. Results from a phase IIa study of Avalanche's...
-
Why TheStreet's Jill Malandrino Thinks The AOL Deal Won't Create A Sympathy Play For Yahoo
Wednesday, May 13, 2015 - 7:04am | 287Read More...Jill Malandrino was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. TheStreet's OptionsProfits Product Development Manager Jill Malandrino commented on the AOL, Inc. (NYSE: AOL) and Verizon Communications Inc. (NYSE: VZ) deal....
-
Top Retail Analyst: Starbucks' New 'Mini' Drinks Cuts Calories But Not Profits
Monday, May 11, 2015 - 8:46am | 283Read More...Starbucks Corporation (NASDAQ: SBUX) will sell a 10-ounce mini Frappuccino at stores in the U.S. and Canada until July 6. Consumers looking to cut back on calories will be happy to know that when made with whole milk, the mini frap will weigh in at 120 calories and 24 grams of sugar – a noticeable...
-
Checking Out Chipotle's Apple Watch App
Friday, April 24, 2015 - 11:58am | 338Read More...Chipotle Mexican Grill, Inc. (NYSE: CMG) released a new app on Friday for the Apple Inc. (NASDAQ: AAPL) Watch. According to Brian Sozzi, CEO and Chief Equities Strategist at Belus Capital Advisors, Chipotle “updated and optimized its existing iPhone app, meaning there are no substantially...
-
Dunkin's CEO Says It's Difficult For McDonald's To Do All-Day Breakfast
Thursday, April 23, 2015 - 4:17pm | 275Read More...In an article published Thursday, TheStreet analyst Brian Sozzi mentioned that Dunkin Donuts of Dunkin Brands Group Inc (NASDAQ: DNKN) had withstood the "breakfast wars" with another quarter of strong breakfast food sales. US same-store sales grew 2.7 percent, up from 1.4 percent in the fourth...
-
Here's What's Wrong With McDonald's
Tuesday, April 21, 2015 - 2:15pm | 410Read More...Brian Sozzi of Belus Capital Advisers wrote an article on TheStreet, detailing what is wrong with McDonald's Corporation (NYSE: MCD). According to Sozzi, McDonald's is likely to report "sagging" U.S. sales in its first quarter earnings report on Wednesday. The analyst added...
-
These Companies Probably Won't Be Acquiring Ariad Pharmaceuticals
Saturday, April 18, 2015 - 10:49am | 338Read More...Adam Feuerstein was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. TheStreet Senior Columnist Adam Feuerstein responded to an article in the Boston Business Journal which suggested that Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA)...
-
Adam Feuerstein Is A Skeptic Of Stem Cell Therapy
Saturday, April 18, 2015 - 10:46am | 259Read More...Adam Feuerstein was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. TheStreet Senior Columnist Adam Feuerstein discussed Cytori Therapeutics Inc (NASDAQ: CYTX) on the show. Overall, Feuerstein was skeptical of stem cell therapy...
-
Expert: Bluebird Bio Is 'One Of The Better Stories In Biotech'
Friday, April 17, 2015 - 3:03pm | 259Read More...Adam Feuerstein was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. TheStreet Senior Columnist Adam Feuerstein discussed bluebird bio Inc (NASDAQ: BLUE) on the show and said that it was “one of the better stories in biotech over...
-
Why Bristol-Myers Squibb Ending A Drug Trial Early Is A Good Thing
Friday, April 17, 2015 - 1:47pm | 221Read More...Adam Feuerstein was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick.. TheStreet Senior Columnist Adam Feuerstein discussed Bristol-Myers Squibb Co (NYSE: BMY) on the show. Feuerstein pointed out that the company announced Friday...
-
TheStreet's Chris Ciaccia On Tesla: Updates, Range Anxiety Will Have Little Impact On Sales
Tuesday, March 17, 2015 - 10:47am | 157Read More...Speaking to Benzinga, TheStreet Technology Editor Chris Ciaccia that Tesla Motors Inc (NASDAQ: TSLA) may release an update to allow 100 percent of a battery's charge to be used, based on comments from sources in the industry. Ciaccia indicated that the batteries only release 97 to 98...
-
Analyst Sits Down With DineEquity CEO, Talks Future Of IHOP And Applebee's
Wednesday, March 4, 2015 - 5:49pm | 384Read More...TheStreet analyst Brian Sozzi joined CEO of DineEquity, Inc. (NYSE: DIN), Julia Stewart, at the world's largest Applebee's in New York City to talk about the future of the restaurant chain. The CEO expressed her enthusiasm around National Pancake Day, which was a resounding success for IHOP,...
-
How Adam Feuerstein Follows The Biotech Sector
Friday, November 14, 2014 - 11:11am | 462Read More...Anyone who trades or invests in biotech stocks knows how volatile they can be, according to Adam Feuerstein. Feuerstein is a senior columnist for TheStreet.com, and he recently joined Benzinga’s #PreMarket Prep to talk about how he keeps track of what’s going on in the biotech...
-
Sozzi: Momentum At VF Corp May Continue With Acquisitions
Monday, October 20, 2014 - 1:52pm | 261Read More...VF Corp (NYSE: VFC) reported strong third quarter results Monday morning. The maker of Timberland and North Face brands was able to impress investors by raising its full year outlook at a time when retailers like J.C. Penney are offering investors cautious and disappointing business updates....
